KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Average (2016 - 2025)

Historic Equity Average for Zimmer Biomet Holdings (ZBH) over the last 17 years, with Q3 2025 value amounting to $12.7 billion.

  • Zimmer Biomet Holdings' Equity Average rose 66.73% to $12.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 billion, marking a year-over-year increase of 66.73%. This contributed to the annual value of $12.5 billion for FY2024, which is 183.23% up from last year.
  • Zimmer Biomet Holdings' Equity Average amounted to $12.7 billion in Q3 2025, which was up 66.73% from $12.5 billion recorded in Q2 2025.
  • In the past 5 years, Zimmer Biomet Holdings' Equity Average registered a high of $12.7 billion during Q4 2021, and its lowest value of $12.1 billion during Q2 2022.
  • For the 5-year period, Zimmer Biomet Holdings' Equity Average averaged around $12.4 billion, with its median value being $12.4 billion (2023).
  • Its Equity Average has fluctuated over the past 5 years, first surged by 754.78% in 2021, then tumbled by 434.39% in 2022.
  • Zimmer Biomet Holdings' Equity Average (Quarter) stood at $12.7 billion in 2021, then decreased by 4.34% to $12.1 billion in 2022, then grew by 3.0% to $12.5 billion in 2023, then decreased by 0.59% to $12.4 billion in 2024, then rose by 1.77% to $12.7 billion in 2025.
  • Its Equity Average stands at $12.7 billion for Q3 2025, versus $12.5 billion for Q2 2025 and $12.4 billion for Q1 2025.